Ignite Creation Date:
2024-05-06 @ 12:34 AM
Last Modification Date:
2024-10-26 @ 10:51 AM
Study NCT ID:
NCT01605864
Status:
COMPLETED
Last Update Posted:
2014-03-24
First Post:
2012-05-16
Brief Title:
Use of Ceftaroline in Hospitalized Patients With Community Acquired Pneumonia
Sponsor:
Albany Medical College
Organization:
Albany Medical College
Study Overview
Official Title:
Ceftaroline Fosamil Versus Standard of Care for Community Acquired Bacterial Pneumonia CABP Clinical Outcomes Among Hospitalized Adults at a Single United States Hospital
Status:
COMPLETED
Status Verified Date:
2012-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CAP
Brief Summary:
Community-acquired bacterial pneumonia which is often called CAP is a bacterial infection in the lungs and is treated with antibiotics Sometimes people need to be in the hospital to be treated for CAP Usually hospitalized persons with CAP are given two antibiotics together These antibiotics usually include a cephalosporin and a macrolide The most commonly used cephalosporin at Albany Medical Center Hospital is ceftriaxone The most commonly used macrolides at Albany Medical Center Hospital are azithromycin and doxycycline
This research is being done to find out how well a new cephalosporin antibiotic called ceftaroline works in combination with a macrolide for the treatment of CAP Ceftaroline is similar to ceftriaxone Ceftaroline was recently approved by the FDA to treat pneumonia in hospitalized patients based on two research studies In one study ceftaroline was better than ceftriaxone In the second study ceftaroline was just as good as ceftriaxone Ceftaroline was very well tolerated in both clinical studies and it was found to be as safe as ceftriaxone
This research is being done to find out how well a new cephalosporin antibiotic called ceftaroline works in combination with a macrolide for the treatment of CAP Ceftaroline is similar to ceftriaxone Ceftaroline was recently approved by the FDA to treat pneumonia in hospitalized patients based on two research studies In one study ceftaroline was better than ceftriaxone In the second study ceftaroline was just as good as ceftriaxone Ceftaroline was very well tolerated in both clinical studies and it was found to be as safe as ceftriaxone
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None